Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$13.47 - $24.89 $434,407 - $802,702
-32,250 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$12.89 - $15.89 $101,805 - $125,499
7,898 Added 32.43%
32,250 $455,000
Q2 2020

Jul 29, 2020

SELL
$8.86 - $15.69 $23,266 - $41,201
-2,626 Reduced 9.73%
24,352 $367,000
Q1 2020

May 14, 2020

BUY
$6.63 - $11.16 $178,864 - $301,074
26,978 New
26,978 $250,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.68B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.